产品编号:M331275
产品规格:250mg
产品价格:面议
| 标准品编号: | M331275 |
| 名称: | N-((R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)pyrazine-2-carboxamide |
| 分子式: | C₂₀H₃₀BN₃O₃ |
| 分子量: | 371.28 |
| 种类: | Building Blocks; Miscellaneous; |
| 应用: | N-((R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)pyrazine-2-carboxamide is a useful synthetic intermediate in the synthesis of (R)-(3-Methyl-1-(pyrazine-2-carboxamido)butyl)boronic Acid (M327105); an impurity of Bortezomib (B675700) which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. |
| 参考文献 | |